- Home
- CCU vs VERA Comparison
CCU vs VERA Comparison
Compare CCU & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCU
- VERA
- Stock Information
- Founded
- CCU 1850
- VERA 2016
- Country
- CCU Chile
- VERA United States
- Employees
- CCU N/A
- VERA N/A
- Industry
- CCU Beverages (Production/Distribution)
- VERA Biotechnology: Pharmaceutical Preparations
- Sector
- CCU Consumer Staples
- VERA Health Care
- Exchange
- CCU Nasdaq
- VERA Nasdaq
- Market Cap
- CCU 2.4B
- VERA 2.0B
- IPO Year
- CCU 1992
- VERA 2021
- Fundamental
- Price
- CCU $12.89
- VERA $23.39
- Analyst Decision
- CCU Strong Sell
- VERA Buy
- Analyst Count
- CCU 2
- VERA 8
- Target Price
- CCU $9.70
- VERA $64.63
- AVG Volume (30 Days)
- CCU 144.5K
- VERA 3.0M
- Earning Date
- CCU 08-06-2025
- VERA 08-07-2025
- Dividend Yield
- CCU 2.13%
- VERA N/A
- EPS Growth
- CCU 67.38
- VERA N/A
- EPS
- CCU 0.47
- VERA N/A
- Revenue
- CCU $3,126,996,945.00
- VERA N/A
- Revenue This Year
- CCU $9.09
- VERA N/A
- Revenue Next Year
- CCU $4.83
- VERA N/A
- P/E Ratio
- CCU $13.77
- VERA N/A
- Revenue Growth
- CCU 15.38
- VERA N/A
- 52 Week Low
- CCU $10.00
- VERA $18.53
- 52 Week High
- CCU $15.75
- VERA $51.61
- Technical
- Relative Strength Index (RSI)
- CCU 44.78
- VERA 49.48
- Support Level
- CCU $12.45
- VERA $20.40
- Resistance Level
- CCU $13.29
- VERA $25.30
- Average True Range (ATR)
- CCU 0.27
- VERA 1.31
- MACD
- CCU 0.03
- VERA -0.02
- Stochastic Oscillator
- CCU 59.84
- VERA 46.25
About CCU Compania Cervecerias Unidas S.A.
United Breweries Co Inc is a multi-category beverage company with operations in Chile, Argentina, Bolivia, Colombia, Paraguay and Uruguay. The company is a player in each one of the beverage categories in which it participates in Chile, including beer, soft drinks, mineral and bottled water, juice, wine, cider and pisco, among others. The Company has three operating segment with respect to its revenues in the geographic areas of commercial activity: Chile; International business and Wine. It generates maximum revenue from Chile.
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.